NAUT

Nautilus Biotechnology Inc

Feb 26 • 04:00PM ET

2.42

-0.47 -16.26 %

Healthcare • Biotechnology • USA • NASD

Today, 4:43 PMNautilus accelerates early access, targets 2027 instrument ramp with runway through 2027 after Q4 2025 non-GAAP EPS -$0.11 beat on zero revenue

Peers: ILMN GH EXAS TXG PACB TWST QTRX QDEL CDNA OMIC

| Held by: VTI VXF DFAC DFAS DCOR AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.50	Insider Own	52.45%	Shs Outstand	126.31M	Perf Week	-16.26%
Market Cap	305.66M	Forward P/E	-	EPS next Y	-0.44	Insider Trans	0.34%	Shs Float	60.06M	Perf Month	8.52%
Enterprise Value	201.23M	PEG	-	EPS next Q	-0.17	Inst Own	26.11%	Short Float	0.51%	Perf Quarter	16.91%
Income	-62.81M	P/S	-	EPS this Y	-26.60%	Inst Trans	1.50%	Short Ratio	1.37	Perf Half Y	242.78%
Sales	0.00M	P/B	1.81	EPS next Y	26.05%	ROA	-27.27%	Short Interest	0.31M	Perf YTD	24.10%
Book/sh	1.34	P/C	2.33	EPS next 5Y	2.17%	ROE	-32.00%	52W High	3.08 -21.43%	Perf Year	69.23%
Cash/sh	1.04	P/FCF	-	EPS past 3/5Y	1.79% -4.55%	ROIC	-32.73%	52W Low	0.62 290.32%	Perf 3Y	35.20%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	13.69% 11.06%	Perf 5Y	-84.59%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	11.15%	Oper. Margin	-	ATR (14)	0.26	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	14.95	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	51.62	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	14.95	EPS Q/Q	18.00%	SMA20	3.29%	Beta	1.32	Target Price	4.00
Payout	-	Debt/Eq	0.16	Sales Q/Q	-	SMA50	13.32%	Rel Volume	1.37	Prev Close	2.89
Employees	155	LT Debt/Eq	0.13	Earnings	Feb 26 BMO	SMA200	85.07%	Avg Volume	225.01K	Price	2.42
IPO	Aug 07, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.43% -	Trades		Volume	309,382	Change	-16.26%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-05-24	Downgrade	Goldman	Neutral → Sell	$1.75
Jun-27-24	Initiated	Guggenheim	Buy	$6
Jun-03-24	Resumed	Jefferies	Hold	$3
Jan-06-22	Initiated	Morgan Stanley	Equal-Weight	$8
Nov-02-21	Initiated	Cowen	Outperform
Aug-04-21	Initiated	Goldman	Neutral	$10
Jul-13-21	Initiated	Jefferies	Buy	$13

Today 04:07PM	Nautilus Biotechnology Inc (NAUT) Q4 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com) -16.26%
08:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results (GlobeNewswire)
Feb-24-26 08:00AM	Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026 (GlobeNewswire) +5.19%
Feb-19-26 04:05PM	Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire) +7.84%
Feb-05-26 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (GlobeNewswire)
08:00AM	Loading…
Jan-28-26 08:00AM	Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson's Disease (GlobeNewswire) -7.62%
Jan-08-26 08:00AM	Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay (GlobeNewswire)
Nov-03-25 08:00AM	Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging (GlobeNewswire) +39.10%
Oct-28-25 08:00AM	Nautilus Biotechnology Reports Third Quarter 2025 Financial Results (GlobeNewswire) +5.93%
Oct-07-25 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 (GlobeNewswire)
Aug-27-25 08:00AM	Nautilus Biotechnology to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Jul-31-25 08:00AM	Nautilus Biotechnology Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-30-25 08:00AM	Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics (GlobeNewswire)
Jul-15-25 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025 (GlobeNewswire) -8.59%
May-27-25 08:00AM	Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire) +5.59%
03:10AM	Loading…
Apr-30-25 03:10AM	Nautilus Biotechnology Inc (NAUT) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions ... (GuruFocus.com) -6.21%
Apr-29-25 01:01PM	Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript (Seeking Alpha) +7.97%
08:00AM	Nautilus Biotechnology Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-16-25 08:00AM	Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 (GlobeNewswire) -6.08%
Feb-28-25 02:16AM	Nautilus Biotechnology Inc (NAUT) Q4 2024 Earnings Call Highlights: Progress in Proteome ... (GuruFocus.com) +11.11%
Feb-27-25 08:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire) -18.18%
Feb-18-25 08:00AM	Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference (GlobeNewswire)
Feb-06-25 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 (GlobeNewswire)
Oct-31-24 08:00AM	Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award (GlobeNewswire)
Oct-30-24 08:00AM	Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference (GlobeNewswire)
03:07AM	Nautilus Biotechnology Inc (NAUT) Q3 2024 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Oct-29-24 08:00AM	Nautilus Biotechnology Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-08-24 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 (GlobeNewswire)
Sep-17-24 08:00AM	Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer (GlobeNewswire)
Aug-14-24 08:00AM	Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
08:00AM	Loading…
Jul-30-24 08:00AM	Nautilus Biotechnology Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-09-24 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 (GlobeNewswire)
May-23-24 08:00AM	Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
May-03-24 12:00PM	Nautilus Biotechnology (NAUT) Upgraded to Buy: Here's What You Should Know (Zacks)
May-01-24 11:11AM	Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call Transcript (Insider Monkey) +9.45%
03:08AM	Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ... (GuruFocus.com)
Apr-30-24 11:54AM	NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q1 2024 (InvestorPlace)
08:00AM	Nautilus Biotechnology Reports First Quarter 2024 Financial Results (GlobeNewswire)
07:36AM	Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings: Narrower Loss Than Expected (GuruFocus.com)
Apr-11-24 08:00AM	Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 (GlobeNewswire)
Feb-28-24 08:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results (GlobeNewswire)
07:36AM	Nautilus Biotechnology Inc (NAUT) Reports Fiscal Year 2023 Financial Results (GuruFocus.com)
Feb-22-24 08:00AM	Nautilus Biotechnology to Participate in the TD Cowen 44 Annual Healthcare Conference (GlobeNewswire)
Feb-07-24 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Nov-30-23 08:00AM	Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award (GlobeNewswire)
Nov-01-23 08:05AM	Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development (GlobeNewswire)
Oct-31-23 08:05AM	Nautilus Biotechnology Reports Third Quarter 2023 Financial Results (GlobeNewswire) +9.40%
Oct-11-23 08:05AM	Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023 (GlobeNewswire)
Sep-06-23 07:30AM	Nautilus Biotechnology to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Aug-04-23 08:00AM	Nautilus Biotechnology to Participate in Upcoming August Investor Conferences (GlobeNewswire)
Aug-02-23 07:30AM	Nautilus Biotechnology Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-11-23 09:23AM	Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023 (GlobeNewswire)
May-24-23 08:05AM	Nautilus Biotechnology to Participate in Upcoming June Investor Conferences (GlobeNewswire)
May-02-23 06:30AM	Nautilus Biotechnology Reports First Quarter 2023 Financial Results (GlobeNewswire) -10.63%
Apr-18-23 04:05PM	Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023 (GlobeNewswire) -6.43%
Mar-23-23 08:00AM	Nautilus Biotechnology to Participate in B. Riley Securities Disruptive Biotech Enabling Technologies Proteomics, Virtual Conference (GlobeNewswire)
Mar-07-23 08:00AM	Nautilus Biotechnology Announces First Access Challenge Winners (GlobeNewswire)
Feb-23-23 06:05AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results (GlobeNewswire) -7.00%
Feb-21-23 08:00AM	Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference (GlobeNewswire) -10.31%
Jan-26-23 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 (GlobeNewswire)
07:45AM	Nautilus Biotechnology Expands to San Diego (GlobeNewswire)
Jan-19-23 08:00AM	Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG) (GlobeNewswire)
Nov-16-22 08:00AM	Nautilus Biotechnology Launches First Access Challenge (GlobeNewswire) -6.47%
Nov-01-22 06:05AM	Nautilus Biotechnology Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-05-22 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 (GlobeNewswire) -7.26%
Sep-23-22 08:00AM	Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit (GlobeNewswire)
Sep-01-22 08:00AM	Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board (GlobeNewswire)
Aug-30-22 08:00AM	Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-11-22 06:30AM	Sujal Patel Is The Co-Founder of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) And Just Spent US$146k On Shares (Simply Wall St.)
Aug-02-22 06:48AM	Nautilus Biotechnology Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-01-22 04:05PM	Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development (GlobeNewswire)
Jul-13-22 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022 (GlobeNewswire)
May-12-22 06:28AM	Trade Alert: The Co-Founder Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT), Sujal Patel, Has Just Spent US$198k Buying A Few More Shares (Simply Wall St.) +6.81%
May-03-22 06:00AM	Nautilus Biotechnology Reports First Quarter 2022 Financial Results (GlobeNewswire)
Apr-12-22 08:00AM	Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development (GlobeNewswire)
Apr-07-22 08:00AM	Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022 (GlobeNewswire)
Apr-04-22 08:00AM	Nautilus Biotechnology to Present at EuPA and AACR Meetings (GlobeNewswire)
Mar-31-22 04:05PM	Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors (GlobeNewswire)
Mar-05-22 07:22AM	What Percentage Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Do Insiders Own? (Simply Wall St.)
Feb-24-22 06:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results (GlobeNewswire) +8.43%
Feb-16-22 04:05PM	Nautilus to Participate in the 42nd Annual Cowen Health Care Conference (GlobeNewswire)
Feb-02-22 01:38PM	Clarius Group, LLC Buys BTC BlackRock Ultra Short-Term Bond ETF, , Vanguard Ultra-Short Bond ... (GuruFocus.com)
Jan-27-22 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022 (GlobeNewswire) -6.75%
Dec-16-21 01:07PM	A look at insider stock sales among Portland-area companies in 2021 (Photos) (American City Business Journals)
Dec-05-21 06:39AM	Insider Buying: The Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Co-Founder Just Bought 1.5% More Shares (Simply Wall St.)
Nov-02-21 08:00AM	Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome (GlobeNewswire) +7.17%
06:00AM	Nautilus Biotechnology Reports Third Quarter 2021 Financial Results (GlobeNewswire)
Oct-11-21 08:00AM	Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021 (GlobeNewswire)
Sep-10-21 10:21AM	Do Insiders Own Lots Of Shares In Nautilus Biotechnology, Inc. (NASDAQ:NAUT)? (Simply Wall St.)
Sep-03-21 09:00AM	Nautilus to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-10-21 06:00AM	Nautilus Biotechnology Reports Second Quarter 2021 Financial Results (GlobeNewswire) -5.01%
Aug-09-21 08:00AM	Nautilus Biotechnology Appoints Karl Voss, Ph.D., as Vice President of Life Sciences Research and Development (GlobeNewswire) +6.68%
Jul-13-21 08:00AM	Nautilus Biotechnology to Announce Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021 (GlobeNewswire)
Jun-17-21 07:00AM	Nautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board (GlobeNewswire)

Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Suzuki Kentaro	Chief Marketing Officer	Nov 06 '25	Buy	1.49	4,000	5,960	4,000	Nov 10 09:29 PM
Patel Sujal M	CEO, President, and Secretary	Sep 05 '25	Buy	0.67	116,500	78,544	10,258,221	Sep 09 04:42 PM
Patel Sujal M	CEO, President, and Secretary	Sep 08 '25	Buy	0.68	83,500	57,031	10,341,721	Sep 09 04:42 PM
Murphy Matthew B.	General Counsel	Sep 04 '25	Buy	0.64	20,000	12,858	74,140	Sep 05 06:34 PM
Mowry Anna	CFO and Treasurer	May 29 '25	Buy	0.77	15,000	11,488	83,000	Jun 02 05:12 PM
Mallick Parag	Chief Scientist	May 08 '25	Buy	0.73	12,000	8,788	20,491,892	May 12 07:19 PM
Mallick Parag	Chief Scientist	May 12 '25	Buy	0.73	1,500	1,098	20,493,392	May 12 07:19 PM
Patel Sujal M	CEO, President, and Secretary	Mar 19 '25	Buy	0.99	53,300	53,028	10,117,788	Mar 21 04:44 PM
Patel Sujal M	CEO, President, and Secretary	Mar 20 '25	Buy	1.00	23,933	23,890	10,141,721	Mar 21 04:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NAUT

Nautilus Biotechnology Inc

Upgrade your FINVIZ experience